NCT00646529View on ClinicalTrials.gov

Long-Term Safety of Symbicort in Asthmatic Children - SAPLING

PHASE3CompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

October 31, 2003

Conditions
Asthma
Interventions
DRUG

budesonide/formoterol (Symbicort)

DRUG

budesonide (Pulmicort)

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY